世界の胃抗分泌薬市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)

GlobalInfoResearchが発行した調査報告書(GIR20SP11444)
◆英語タイトル:Global Gastric Antisecretory Drug Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
◆商品コード:GIR20SP11444
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年9月25日(※2024年版があります。お問い合わせください。)
◆ページ数:108
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療、製薬、バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、胃抗分泌薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。胃抗分泌薬の種類別市場規模(H2受容体拮抗薬、胃プロトンポンプ阻害薬、その他)、用途別市場規模(消化不良、消化性潰瘍、胃食道逆流、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Bayer、Takeda、Jiangsu Aosaikang、Cadila Pharmaceuticals、Altana Pharma、AstraZeneca、Luoxin、Pfizer、Eisai、NCPC
・地域別グローバル市場分析 2015年-2020年
・胃抗分泌薬の北米市場(アメリカ、カナダ、メキシコ)
・胃抗分泌薬のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・胃抗分泌薬のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・胃抗分泌薬の南米市場(ブラジル、アルゼンチン)
・胃抗分泌薬の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:H2受容体拮抗薬、胃プロトンポンプ阻害薬、その他
・用途別分析:消化不良、消化性潰瘍、胃食道逆流、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論
【レポートの概要】

Market Overview
The Gastric Antisecretory Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Gastric Antisecretory Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

Market segmentation
Gastric Antisecretory Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Gastric Antisecretory Drug market has been segmented into
H2-receptor Antagonists
Gastric Proton Pump Inhibitors
Others

By Application, Gastric Antisecretory Drug has been segmented into:
Dyspepsia
Peptic Ulcer
Gastroesophageal Reflux
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Gastric Antisecretory Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Gastric Antisecretory Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Gastric Antisecretory Drug market.

The report offers in-depth assessment of the growth and other aspects of the Gastric Antisecretory Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Gastric Antisecretory Drug Market Share Analysis
Gastric Antisecretory Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Gastric Antisecretory Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Gastric Antisecretory Drug sales, revenue and market share for each player covered in this report.

The major players covered in Gastric Antisecretory Drug are:
Bayer
Takeda
Jiangsu Aosaikang
Cadila Pharmaceuticals
Altana Pharma
AstraZeneca
Luoxin
Pfizer
Eisai
NCPC

Among other players domestic and global, Gastric Antisecretory Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gastric Antisecretory Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Gastric Antisecretory Drug, with price, sales, revenue and global market share of Gastric Antisecretory Drug in 2018 and 2019.
Chapter 3, the Gastric Antisecretory Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gastric Antisecretory Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Gastric Antisecretory Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Gastric Antisecretory Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

1 Market Overview
1.1 Gastric Antisecretory Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Gastric Antisecretory Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 H2-receptor Antagonists
1.2.3 Gastric Proton Pump Inhibitors
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Gastric Antisecretory Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Dyspepsia
1.3.3 Peptic Ulcer
1.3.4 Gastroesophageal Reflux
1.3.5 Others
1.4 Overview of Global Gastric Antisecretory Drug Market
1.4.1 Global Gastric Antisecretory Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer SWOT Analysis
2.1.4 Bayer Product and Services
2.1.5 Bayer Gastric Antisecretory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Takeda
2.2.1 Takeda Details
2.2.2 Takeda Major Business
2.2.3 Takeda SWOT Analysis
2.2.4 Takeda Product and Services
2.2.5 Takeda Gastric Antisecretory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Jiangsu Aosaikang
2.3.1 Jiangsu Aosaikang Details
2.3.2 Jiangsu Aosaikang Major Business
2.3.3 Jiangsu Aosaikang SWOT Analysis
2.3.4 Jiangsu Aosaikang Product and Services
2.3.5 Jiangsu Aosaikang Gastric Antisecretory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Cadila Pharmaceuticals
2.4.1 Cadila Pharmaceuticals Details
2.4.2 Cadila Pharmaceuticals Major Business
2.4.3 Cadila Pharmaceuticals SWOT Analysis
2.4.4 Cadila Pharmaceuticals Product and Services
2.4.5 Cadila Pharmaceuticals Gastric Antisecretory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Altana Pharma
2.5.1 Altana Pharma Details
2.5.2 Altana Pharma Major Business
2.5.3 Altana Pharma SWOT Analysis
2.5.4 Altana Pharma Product and Services
2.5.5 Altana Pharma Gastric Antisecretory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca Product and Services
2.6.4 AstraZeneca Gastric Antisecretory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Luoxin
2.7.1 Luoxin Details
2.7.2 Luoxin Major Business
2.7.3 Luoxin Product and Services
2.7.4 Luoxin Gastric Antisecretory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Product and Services
2.8.4 Pfizer Gastric Antisecretory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Eisai
2.9.1 Eisai Details
2.9.2 Eisai Major Business
2.9.3 Eisai Product and Services
2.9.4 Eisai Gastric Antisecretory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 NCPC
2.10.1 NCPC Details
2.10.2 NCPC Major Business
2.10.3 NCPC Product and Services
2.10.4 NCPC Gastric Antisecretory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Gastric Antisecretory Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Gastric Antisecretory Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Gastric Antisecretory Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Gastric Antisecretory Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Gastric Antisecretory Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Gastric Antisecretory Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Gastric Antisecretory Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
4.3 Europe Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
4.5 South America Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Gastric Antisecretory Drug Sales, Revenue and Market Share by Country
5.1.1 North America Gastric Antisecretory Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Gastric Antisecretory Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
5.3 Canada Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Gastric Antisecretory Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Gastric Antisecretory Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Gastric Antisecretory Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
6.3 UK Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
6.4 France Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
6.5 Russia Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
6.6 Italy Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Gastric Antisecretory Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Gastric Antisecretory Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Gastric Antisecretory Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
7.3 Japan Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
7.4 Korea Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
7.5 India Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
7.7 Australia Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Gastric Antisecretory Drug Sales, Revenue and Market Share by Country
8.1.1 South America Gastric Antisecretory Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Gastric Antisecretory Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Gastric Antisecretory Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Gastric Antisecretory Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Gastric Antisecretory Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Gastric Antisecretory Drug Sales and Market Share by Type (2015-2020)
10.2 Global Gastric Antisecretory Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Gastric Antisecretory Drug Price by Type (2015-2020)
11 Global Gastric Antisecretory Drug Market Segment by Application
11.1 Global Gastric Antisecretory Drug Sales Market Share by Application (2015-2020)
11.2 Global Gastric Antisecretory Drug Revenue Market Share by Application (2015-2020)
11.3 Global Gastric Antisecretory Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Gastric Antisecretory Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Gastric Antisecretory Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Gastric Antisecretory Drug Market Forecast (2021-2025)
12.2.2 Europe Gastric Antisecretory Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Gastric Antisecretory Drug Market Forecast (2021-2025)
12.2.4 South America Gastric Antisecretory Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Gastric Antisecretory Drug Market Forecast (2021-2025)
12.3 Gastric Antisecretory Drug Market Forecast by Type (2021-2025)
12.3.1 Global Gastric Antisecretory Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Gastric Antisecretory Drug Market Share Forecast by Type (2021-2025)
12.4 Gastric Antisecretory Drug Market Forecast by Application (2021-2025)
12.4.1 Global Gastric Antisecretory Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Gastric Antisecretory Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

...

【掲載企業】

Bayer、Takeda、Jiangsu Aosaikang、Cadila Pharmaceuticals、Altana Pharma、AstraZeneca、Luoxin、Pfizer、Eisai、NCPC

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の胃抗分泌薬市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)(Global Gastric Antisecretory Drug Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。